Use of thyroid hormones in hypothyroid and euthyroid patients: a THESIS* survey of Belgian specialists *THESIS: treatment of hypothyroidism in Europe by specialists: an international survey
Year: 2022
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Hypothyroidism is a topic that continues to provoke debate and controversy with regards to specific indications, type of thyroid hormone substitution and efficacy. We investigated the use of thyroid hormones in clinical practice in Belgium, a country where currently only levothyroxine (LT4) tablet formulations are available. METHOD: Members of the Belgian Endocrine Society were invited to respond to an online questionnaire. Results were compared with those from other THESIS surveys. RESULTS: Eighty (50%) of the invited 160 individuals, completed the questionnaire. LT4 was the first treatment of choice for all respondents. As secondary choice, some also prescribed liothyronine (LT3) and LT4 + LT3 combinations (2 and 7 respondents, respectively). Besides hypothyroidism, 34 and 50% of respondents used thyroid hormones for infertile euthyroid TPOAb positive women and the treatment of a growing non-toxic goiter, respectively. Had alternative formulations of LT4 to tablets been available (soft gel or liquid L-T4), 2 out of 80 (2.5%) participants would consider them for patients achieving biochemical euthyroidism but remaining symptomatic. This proportion was higher in case of unexplained poor biochemical control of hypothyroidism (13.5%) and in patients with celiac disease or malabsorption or interfering drugs (10%). In symptomatic euthyroid patients, 20% of respondents would try combined LT4 + LT3 treatment. Psychosocial factors were highlighted as the main contributors to persistent symptoms. CONCLUSIONS: LT4 tablets is the preferred treatment for hypothyroidism in Belgium. A minority of the respondents would try combined LT4 + LT3 in symptomatic but biochemically euthyroid patients. Thyroid hormones are prescribed for euthyroid infertile women with thyroid autoimmunity and patients with non-toxic goiter, a tendency noted in other European countries, despite current evidence of lack of benefit.
Source: Thyroid Research
Authors: Maria-Cristina Burlacu, Roberto Attanasio, Laszlo Hegedüs, Endre V. Nagy, Enrico Papini, Petros Perros, Kiswendsida Sawadogo, Marie Bex, Bernard Corvilain, Chantal Daumerie, Brigitte Decallonne, Damien Gruson, Bruno Lapauw, Rodrigo Moreno Reyes, Patrick Petrossians, Kris Poppe, Annick Van den Bruel, David Unuane
Institutions: Cliniques Universitaires Saint-Luc, UCLouvain, IRCCS Ospedale Galeazzi - Sant'Ambrogio, University of Southern Denmark, Odense University Hospital, University of Debrecen, Ospedale Regina Apostolorum, Royal Victoria Infirmary, Universitair Ziekenhuis Leuven, Université Libre de Bruxelles, Erasmus Hospital, Ghent University Hospital, University of Liège, Centre Hospitalier Universitaire de Liège, Centre Hospitalier Universitaire de Saint-Pierre, AZ Sint-Jan, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W4220706776
